Drs. Krivda, Watson, and Logemann are from Walter Reed National Military Medical Center, Bethesda, Maryland. Drs. Krivda and Logemann are from the Department of Dermatology, and Dr. Waston is from the Department of Research Programs. Dr. Lyford is from the Department of Dermatology, Naval Medical Center San Diego, California.
Cutis. 2024 May;113(5):200-215. doi: 10.12788/cutis.1015.
This retrospective observational study investigates skin cancer prevalence and care patterns within the Military Health System (MHS) from 2017 to 2022. Utilizing the MHS Management Analysis and Reporting Tool (most commonly called M2), we analyzed more than 5 million patient encounters and documented skin cancer prevalence in the MHS beneficiary population utilizing available demographic data. Notable findings included an increased prevalence of skin cancer in the military population compared with the civilian population, a substantial decline in direct care (DC) visits at military treatment facilities compared with civilian purchased care (PC) visits, and a decreased total number of visits during COVID-19 restrictions.
本回顾性观察研究调查了 2017 年至 2022 年期间军人健康系统 (MHS) 中的皮肤癌患病率和护理模式。我们利用 MHS 管理分析和报告工具 (通常称为 M2)，分析了超过 500 万例患者就诊记录，并利用现有人口统计学数据记录了 MHS 受益人群中的皮肤癌患病率。值得注意的发现包括与平民相比，军人中皮肤癌的患病率增加，与平民购买的护理相比，军事治疗设施的直接护理 (DC) 就诊次数大幅下降，以及在 COVID-19 限制期间就诊次数减少。
